Healthcare
Thursday, July 21, 2016
UPDATE 1-Galenica to buy biotech firm Relypsa for $1.5 bln before break-up
July 21 (Reuters) - Galenica has agreed to buy U.S.
biotech firm Relypsa for $1.53 billion in cash to
strengthen its Vifor Pharma unit ahead of splitting up the Swiss
healthcare group.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment